loadpatents
name:-0.22508192062378
name:-0.024821996688843
name:-0.010890960693359
Moyo; Victor Patent Filings

Moyo; Victor

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moyo; Victor.The latest application filed is for "methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan".

Company Profile
9.15.44
  • Moyo; Victor - Ringoes NJ
  • Moyo; Victor - Concord MA
  • Moyo; Victor - Rinyoes NJ US
  • Moyo; Victor - Cambridge MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods for treating pancreatic cancer using combination therapies
Grant 11,369,597 - Bayever , et al. June 28, 2
2022-06-28
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20220096458 - Bayever; Eliel ;   et al.
2022-03-31
Targeted Liposomal Gemcitabine And Methods Thereof
App 20210154140 - NIYIKIZA; Clet ;   et al.
2021-05-27
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 10,980,795 - Bayever , et al. April 20, 2
2021-04-20
Targeted liposomal gemcitabine compositions and methods thereof
Grant 10,940,112 - Niyikiza , et al. March 9, 2
2021-03-09
Combination Therapy for Cancer Treatment
App 20200268742 - Blanchette; Sarah F. ;   et al.
2020-08-27
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 10,744,130 - Bayever , et al. A
2020-08-18
Combination therapy for cancer treatment
Grant 10,478,428 - Blanchette , et al. Nov
2019-11-19
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20190117643 - Bayever; Eliel ;   et al.
2019-04-25
Use Of Erbb3 Inhibitors In The Treatment Of Triple Negative And Basal-like Breast Cancers
App 20190119401 - MOYO; Victor ;   et al.
2019-04-25
Methods For Treating Pancreatic Cancer Using Combination Therapies
App 20190117644 - Bayever; Eliel ;   et al.
2019-04-25
Combination Therapy For Cancer Treatment
App 20180117034 - Blanchette; Sarah F. ;   et al.
2018-05-03
Combination therapy for treating HER2-positive cancers
Grant 9,913,901 - Moyo , et al. March 13, 2
2018-03-13
Combination therapy for cancer treatment
Grant 9,895,365 - Blanchette , et al. February 20, 2
2018-02-20
Methods for Treating Pancreatic Cancer Using Combination Therapies
App 20180008591 - Bayever; Eliel ;   et al.
2018-01-11
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20170368056 - Bayever; Eliel ;   et al.
2017-12-28
Targeted Liposomal Gemcitabine Compositions And Methods Thereof
App 20170319482 - NIYIKIZA; Clet ;   et al.
2017-11-09
Use Of Erbb3 Inhibitors In The Treatment Of Triple Negative And Basal-like Breast Cancers
App 20170291957 - MOYO; Victor ;   et al.
2017-10-12
Combination Therapies For Treating Her2-positive Cancers That Are Resistant To Her2-targeted Therapies
App 20170258903 - Espelin; Christopher W. ;   et al.
2017-09-14
Methods And Compositions For Improving Outcomes Of Liposomal Chemotherapy
App 20170231911 - GERETTI; Elena ;   et al.
2017-08-17
Methods for treating pancreatic cancer using combination therapies
Grant 9,717,724 - Bayever , et al. August 1, 2
2017-08-01
Treatment Of Pancreatic Cancer With Liposomal Irinotecan
App 20170202840 - Bayever; Eliel ;   et al.
2017-07-20
Combination Therapies for Treating Her2-Positive Cancers that are Resistant to Her2-Targeted Therapies
App 20170080087 - ESPELIN; CHRISTOPHER ;   et al.
2017-03-23
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20170065578 - Bayever; Eliel ;   et al.
2017-03-09
Combination Therapy For Cancer Treatment
App 20170049767 - BLANCHETTE; SARAH F. ;   et al.
2017-02-23
Methods For Treating Pancreatic Cancer Using Combination Therapies
App 20170049768 - Bayever; Eliel ;   et al.
2017-02-23
Combination Therapies For Treating Her2-positive Cancers
App 20170022290 - MOYO; VICTOR ;   et al.
2017-01-26
Methods for Treating Pancreatic Cancer Using Combination Therapies
App 20160375004 - BAYEVER; ELIEL ;   et al.
2016-12-29
Use of ERBB3 inhibitors in the treatment of triple negative and basal-like breast cancers
Grant 9,518,130 - Moyo , et al. December 13, 2
2016-12-13
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 9,492,442 - Bayever , et al. November 15, 2
2016-11-15
Liposomes Useful For Non-invasive Imaging And Drug Delivery
App 20160303264 - HENDRIKS; BART S. ;   et al.
2016-10-20
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 9,452,162 - Bayever , et al. September 27, 2
2016-09-27
Combination Therapy For Treating Her2-positive Cancers
App 20160250328 - Moyo; Victor ;   et al.
2016-09-01
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20160228428 - Bayever; Eliel ;   et al.
2016-08-11
Methods And Compositions For Improving Outcomes Of Liposomal Chemotherapy
App 20160184227 - GERETTI; ELENA ;   et al.
2016-06-30
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 9,364,473 - Bayever , et al. June 14, 2
2016-06-14
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Grant 9,339,497 - Bayever , et al. May 17, 2
2016-05-17
Methods for Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20160074382 - BAYEVER; ELIEL ;   et al.
2016-03-17
Methods And Compositions For Improving Outcomes Of Liposomal Chemotherapy
App 20160067182 - GERETTI; ELENA ;   et al.
2016-03-10
Combination Therapies For Treating Her2-positive Cancers That Are Resistant To Her2-targeted Therapies
App 20160045596 - Geretti; Elena ;   et al.
2016-02-18
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20150374682 - BAYEVER; ELIEL ;   et al.
2015-12-31
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20150328156 - BAYEVER; ELIEL ;   et al.
2015-11-19
Overcoming Resistance To Erbb Pathway Inhibitors
App 20150231238 - Garcia; Gabriela ;   et al.
2015-08-20
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
App 20150182521 - Bayever; Eliel ;   et al.
2015-07-02
Dosage And Administration Of Bispecific Scfv Conjugates In Combination With Anti-cancer Therapeutics
App 20150139936 - Frye; Sasha ;   et al.
2015-05-21
Use Of Erbb3 Inhibitors In The Treatment Of Triple Negative And Basal-like Breast Cancers
App 20150132292 - MOYO; Victor ;   et al.
2015-05-14
Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers
Grant 8,895,001 - Moyo , et al. November 25, 2
2014-11-25
Anti-erbb3 Antibodies In Combination With Paclitaxel For Treatment Of Gynecological Cancers
App 20140248280 - Kubasek; William ;   et al.
2014-09-04
Methods For Preventing Toxic Drug-drug Interactions In Combination Therapies Comprising Anti-erbb3 Agents
App 20140234317 - Onsum; Matthew David ;   et al.
2014-08-21
Use Of Inhibitors Of Egfr-family Receptors In The Treatment Of Hormone Refractory Breast Cancers
App 20140134170 - Garcia; Gabriela ;   et al.
2014-05-15
Dosage And Administration Of Bispecific Scfv Conjugates
App 20140017264 - McDonagh; Charlotte ;   et al.
2014-01-16
Use Of Erbb3 Inhibitors In The Treatment Of Triple Negative And Basal-like Breast Cancers
App 20130034548 - Moyo; Victor ;   et al.
2013-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed